In vivo dosimetry in pelvic brachytherapy

Orla Anne Houlihan; Geraldine Workman; Alan R Hounsell; Kevin M Prise; Suneil Jain

doi:10.1259/bjr.20220046

In vivo dosimetry in pelvic brachytherapy

Br J Radiol. 2022 Sep 1;95(1137):20220046. doi: 10.1259/bjr.20220046. Epub 2022 Aug 10.

Authors

Orla Anne Houlihan^{1

2}, Geraldine Workman³, Alan R Hounsell^{2

3}, Kevin M Prise², Suneil Jain^{1

2}

Affiliations

¹ Department of Clinical Oncology, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK.
² Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
³ Radiotherapy Physics, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK.

Abstract

This paper describes the potential role for in vivo dosimetry in the reduction of uncertainties in pelvic brachytherapy, the pertinent factors for consideration in clinical practice, and the future potential for in vivo dosimetry in the personalisation of brachytherapy.

Publication types

Review

MeSH terms

Brachytherapy*
Humans
In Vivo Dosimetry*
Radiometry
Radiotherapy Dosage
Uncertainty